Positon 30g cream

POSITON Tubes 30g

With prescription

Medicines should be kept out of the reach of children

Do not throw away any medicines via wastewater or household waste. Deposit any containers

and medicine you no longer need in the SIGRE point of your pharmacy. Ask your pharmacist how to throw away medicines you no longer use.These measures willhelp to protect the environment.

You can also report side effects directly via the Spanish System of Pharmacovigilance of Medicinal Products for Human Use: www.notificaRAM.es.

COMPOSITION

Per 100 grams of cream:

Triamcinolone acetonide (I.N.N.) .................100mg

Neomycin (I.N.N.), sulphate..........................250mg

Nystatin (I.N.N.) .............................. 10,000,000 I.U.

 Excipients: 

polyoxil stearate 40, self-emulsifying glyceryl monostearate, white soft paraffin, cetostearyl alcohol, aluminium hydroxide (dry gel), titanium dioxide, sorbitol solution, propylene glycol, ethylenediamine dichoride, methylparaben (E 218), propilparaben (E 216), sorbic acid (E 200), dimethicone, water, s.q.

 ACTION

POSITON combines a corticoid anti-inflammatory drug (triamcinolone acetonide), a wide range antibacterial antibiotic (neomycin sulphate), and an antibiotic with excellent antifungal properties (nystatin), all prepared in an evanescent cream.

 INDICATIONS

To be used in the following processes, especially where there is a risk of a bacterial or secondary moniliasic infection:

Dermatitis (atopical eczematous, by stasis, nummular, by contact, exudative, seborrheic and neurodermatitis).

Anogenital pruritus.

Eczema.

Chronic simple lichen.

Cutaneous moniliasis.

Superficial cutaneous infections.

DOSE AND ADMINISTRATION

Apply 2-3 times daily, following doctor's instructions.

WARNING ABOUT EXCIPIENTS

Because it contains sorbic acid as an excipient, in cutaneous use it can causes dermatitis

COUNTERINDICATIONS

Active cutaneous tuberculosis.

Cutaneous manifestations of syphilis.

Viral dermatitis.

Sensitivity to any of the ingredients.

PRECAUTIONS

Do not use in ocular therapy on in areas close to the eyes.

During pregnancy avoid applying large doses, on extensive areas or prolonged treatment.

Do not apply occlusive bandage on very large areas of the skin, as it may occur systemic absorption with risk of toxicity.

It is recommended to stop the treatment gradually

Contact your doctor if you have blurred vision or other visual disturbances.

INCOMPATIBILITIES AND INTERACTTIONS

Unknown.

SECONDARY EFFECTS

Hypensensitivity reactions.

The topical administration produces the following undesirable effects on the skin in cases of prolonged treatment:

In treatments with occlusive bandaging, systemic secondary effects may appear:

With an unknown frequency (frequency can not be estimated from the data available): blurred vision.

COMUNICATION OF SIDE EFFECTS

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish System of Pharmacovigilance of Medicinal Products for Human Use: www.notificaRAM.es. By reporting side effects you can help provide more information on the safety of this medicine.

OVERDOSE

In case of an overdose or accidental intake, consult the Toxicological Information Service. Tlf.

915620420.